ID: ALA2282814

Max Phase: Preclinical

Molecular Formula: C10H14N6

Molecular Weight: 218.26

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCc1nc2nc(N)nc(N)c2nc1CC

Standard InChI:  InChI=1S/C10H14N6/c1-3-5-6(4-2)14-9-7(13-5)8(11)15-10(12)16-9/h3-4H2,1-2H3,(H4,11,12,14,15,16)

Standard InChI Key:  BUZKILZDXOORCH-UHFFFAOYSA-N

Associated Targets(non-human)

Dihydrofolate reductase 1239 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 218.26Molecular Weight (Monoisotopic): 218.1280AlogP: 0.71#Rotatable Bonds: 2
Polar Surface Area: 103.60Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 1.81CX LogP: 0.98CX LogD: 0.98
Aromatic Rings: 2Heavy Atoms: 16QED Weighted: 0.77Np Likeness Score: -0.50

References

1. Kiani YS, Kalsoom S, Riaz N.  (2013)  In silico ligand-based pharmacophore model generation for the identification of novel Pneumocystis carinii DHFR inhibitors,  22  (2): [10.1007/s00044-012-0082-2]

Source